[1] |
LI Yulei, LI Ping, MA Jinzhu, LING Yunyun, ZUO Mengyu, DING Zhen Yu, XUE Liangjun.
Effects of a new bromobenzene substituted trifluoromethyl benzocyclopentanone WW02 on the proliferation of lung cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(6): 645-652.
|
[2] |
HUANG Xiaomei, ZHI Hui, CHEN Hao, LU Linming, ZHU Xiaoqun, WANG Lizhen, ZHOU Jue, PANG Jinjin, XU Jinliang.
Effects of the proliferation, migration and apoptosis of AHVAC-Ⅰ on gastric cancer MKN-28 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 270-276.
|
[3] |
DING Jiamin, WANG Youdi, ZHAO Xiali, JIANG Genfeng, CHEN Siwen, HONG Chengcheng, LI Shuqin, HU Weihua.
Study on the treatment of thin endometrium with growth hormone and vitamin E
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 857-862.
|
[4] |
DING Hao, GAO Zhenhua, ZHENG Yun.
Research progress of microRNA in diagnosis and treatment of prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 696-708.
|
[5] |
WANG Xinli, XU Xiaqing, FANG Hanbing, GUO Yuzhong.
Study of TPA on enhancing the anti-tumor effects of cisplatin and reducing its renal toxicity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 535-543.
|
[6] |
LI Yanyan, FANG Xiaojie, YIN Xin, SUN Xi, RAO Chunhui.
circZNF124 regulates the proliferation, migration and invasion of colorectal cancer SW620 cells by targeting miR-4262
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1231-1239.
|
[7] |
JIANG Yuhua, ZHI Hui, LU Linming, TIAN Dahao, WANG Xiaoqing, GE Yu, XIE Shangfu, WANG Qi.
AHVAC-I reverses tumor growth of cancer-associated fibroblasats in gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 389-394.
|
[8] |
WEI Songchang, YANG Hongqi, ZHANG Hongjuan, SHI Xiaoli, REN Kaiwen.
Correlation between the expression of RON protein and CXC chemokine receptor 4 protein and abiraterone resistance in patients with castration-resistant prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 414-422.
|
[9] |
XIE Yan, LI Cheng, ZHANG Lulu, YU Fei, ZANG Shiming, FU Jingjing, LIU Lu, WANG Feng.
Study on binding of 68Ga-PSMA-I&T to newly diagnosed prostate cancer foci
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1379-1385.
|
[10] |
PENG Fusheng, HUANG Xiaohui, LI Peng, TANG Jian'er.
miR-34a inhibits proliferation of prostate cancer LNCaP cells by regulating androgen receptor gene
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 10-17.
|
[11] |
HOU Bin, HUANG Weiping, YIN Zhongpu, HU Shousen.
lncRNA PCAT19 inhibits the proliferation and invasion of nasopharyngeal carcinoma cells by adsorbing miR-142-5p and regulating the expression of ING3 gene
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 721-727.
|
[12] |
CAO Ying, TU Linglan, WANG Xiaoju, ZHENG Xiaoliang.
Progress on TMPRSS2-ERG fusion gene product transcription regulation mechanism in prostate cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 791-795.
|
[13] |
XU Shenghua, GAO Zhuo, WANG Jianfeng.
Preparation of genistein combined polysaccharide liposomes and its inhibitory effects on prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 393-400.
|
[14] |
HUANG Houbao.
PROfound: A new hope for precise treatment of prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 144-150.
|
[15] |
XIE Yan, LI Cheng, ZHANG Lulu, ZHAO Zhenyu, HUANG Shanshan, WANG Yongsheng, TANG Yuanxiang, WANG Feng.
Study on the specific binding of 68Ga-PSMA-I&T to prostate cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1321-1329.
|